After completing my PhD, I left full-time research to work with Bruker as an Applications and Technical Specialist. I was responsible for customer training and method development/implementation on customer sites for the suite of mass spectrometer (MS) systems. In 2015, I commenced as manager of the MS protein characterisation group in the Global Bioanalytical Sciences department, Division of Product Development for CSL.
My industry roles gave me in-depth knowledge around how MS analytical technology can be used to address challenges faced in multiple research settings. Since returning to university research in April 2017, I have used the expertise and opportunities from this time to engage with academic and industry collaborators to... Read more
About me
After completing my PhD, I left full-time research to work with Bruker as an Applications and Technical Specialist. I was responsible for customer training and method development/implementation on customer sites for the suite of mass spectrometer (MS) systems. In 2015, I commenced as manager of the MS protein characterisation group in the Global Bioanalytical Sciences department, Division of Product Development for CSL.
My industry roles gave me in-depth knowledge around how MS analytical technology can be used to address challenges faced in multiple research settings. Since returning to university research in April 2017, I have used the expertise and opportunities from this time to engage with academic and industry collaborators to support fundamental and translational research. This involves using MS approaches for cancer, biopharma, food, and environmental research.
About me
Doctor of Philosophy The University of Adelaide
Bachelor of Medical and Pharmaceutical Biotechnology with Honours University of South Australia
Research
Research since 2008 is shown below. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2019 |
Open access
15
15
14
|
2016 |
Open access
18
17
|
2013 |
14
13
1
|
Year | Output |
---|---|
2020 |
Open access
|
2019 |
Open access
11
10
8
|
2019 |
Open access
7
1
2
|
2019 |
Open access
15
15
14
|
2019 |
3
3
6
|
2019 |
8
|
2018 |
Open access
1
1
3
|
2018 |
Open access
4
5
17
|
2016 |
Open access
8
8
10
|
2016 |
Open access
18
17
|
2015 |
Open access
33
52
6
|
2013 |
14
13
1
|
2012 |
Open access
|
2012 |
26
26
1
|
2012 |
Open access
22
18
|
2011 |
33
29
|
2010 |
5
5
|
2010 |
3
|
2009 |
18
17
|
External engagement & recognition
Organisation | Country |
---|---|
AgriBio Centre | AUSTRALIA |
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology | AUSTRALIA |
Boehringer Ingelheim Pharma GmbH & Co. KG | GERMANY |
Bruker | AUSTRALIA |
Bruker Biosciences | UNITED STATES |
Coopers Brewery | AUSTRALIA |
CSL Limited | AUSTRALIA |
Flinders University | AUSTRALIA |
Griffith University | AUSTRALIA |
Institute of Medical and Veterinary Science | AUSTRALIA |
Ishikawa Hospital | UNITED STATES |
Justus Liebig University Giessen | GERMANY |
La Trobe University | AUSTRALIA |
Macquarie University | AUSTRALIA |
Molecular Genetics | AUSTRALIA |
Monash Medical Centre | AUSTRALIA |
Monash University | AUSTRALIA |
Proteomics International | AUSTRALIA |
Queen Elizabeth Hospital | AUSTRALIA |
Royal Adelaide Hospital | AUSTRALIA |
Royal Children's Hospital, Victoria | AUSTRALIA |
SA Pathology | AUSTRALIA |
Sechenov University | RUSSIAN FEDERATION |
University of Adelaide | AUSTRALIA |
University of Edinburgh | UNITED KINGDOM |
University of Melbourne | AUSTRALIA |
University of Newcastle | AUSTRALIA |
University of Queensland | AUSTRALIA |
University of Science, Malaysia | MALAYSIA |
University of South Australia | AUSTRALIA |
University of Sydney | AUSTRALIA |
University of Technology Sydney | AUSTRALIA |
University of Western Australia | AUSTRALIA |
Walter and Eliza Hall Institute of Medical Research | AUSTRALIA |
External engagement & recognition
Engagement/recognition | Year |
---|---|
ChairCSL Science Day 2016 |
2016 |